Skip to main content
. 2024 Mar 22;9(4):e10663. doi: 10.1002/btm2.10663

FIGURE 6.

FIGURE 6

Make up of unique vaccine formulations that utilize a TLR agonist divided by the combination material it is formulated with. The number of unique vaccine formulations as well as the resulting percent of the whole space is provided.